NCT06526520 Relaxin Measurement in Different Endometrial Preparation Approaches for Frozen Embryo Transfer
| NCT ID | NCT06526520 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ART Fertility Clinics LLC |
| Condition | Frozen Embryo Transfer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5 participants in total. It began in 2024-08-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the levels of Relaxin in different types of endometrial preparation for a frozen embryo transfer cycle. Up to now it is unclear, whether ovulation with a functional corpus luteum (CL) will be present in a natural proliferative phase (NPP) endometrial preparation approach.
Eligibility Criteria
Inclusion Criteria: * regular menstrual cycles Exclusion Criteria: * abnormal findings of the ovaries (e.g endometriosis) * Intake of any hormones within 3 months of study start * desire to become pregnant
Contact & Investigator
Barbara Lawrenz, PhD
PRINCIPAL INVESTIGATOR
ART Fertility Clinic
Frequently Asked Questions
Who can join the NCT06526520 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Frozen Embryo Transfer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06526520 currently recruiting?
Yes, NCT06526520 is actively recruiting participants. Contact the research team at barbara.lawrenz@artfertilityclinics.com for enrollment information.
Where is the NCT06526520 trial being conducted?
This trial is being conducted at Abu Dhabi, United Arab Emirates.
Who is sponsoring the NCT06526520 clinical trial?
NCT06526520 is sponsored by ART Fertility Clinics LLC. The principal investigator is Barbara Lawrenz, PhD at ART Fertility Clinic. The trial plans to enroll 5 participants.